Draganfly Inc. (DFLY) has added Jamie P. Dwyer M.D. to its Board of Advisors.
Dr. Dwyer is a professor of medicine at Vanderbilt University, President of the Collaborative Study Group, and Co-Founder of Innovative Renal Care. Previously he served on the faculty at the Mayo Clinic.
CEO of Draganfly, Cameron Chell said the company is excited and truly honored to have Dr. Jamie Dwyer join Draganfly’s Board of Advisors.
"Dr. Dwyer brings an incredible understanding and experience with FDA processes and will be key in evolving our Vital Intelligence technology.”
“Draganfly has impressed me with the work they have done with their Smart Vital assessment platform and telehealth app. I am honored to assist a company that has built a solid foundation for innovation within the telehealth sector,” said Dwyer.
Dwyer holds an Sc.B degree in mathematics and Latin from Brown University, and an M.D. with Distinction from Brown University Medical School. He trained in Internal Medicine at Mayo Clinic Florida, where he served as Chief Medical Resident. He trained in Nephrology and Clinical Research at VUMC. After a faculty appointment at Mayo Clinic, he joined the Nephrology Division of VUMC in 2008.
Draganfly Inc. is up 0.98 per cent to C$3.08 per share.